Endonovo Therapeutics Inc (ENDV)
0.0025
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Endonovo Therapeutics Debt to Equity Ratio: -0.2934 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.2934 |
| September 30, 2023 | -0.3074 |
| June 30, 2023 | -0.3165 |
| March 31, 2023 | -0.2832 |
| December 31, 2022 | -0.2223 |
| September 30, 2022 | -0.3693 |
| June 30, 2022 | -0.384 |
| March 31, 2022 | -0.4043 |
| December 31, 2021 | -0.4552 |
| September 30, 2021 | -0.3717 |
| June 30, 2021 | -0.3921 |
| March 31, 2021 | -0.4217 |
| December 31, 2020 | -0.4615 |
| September 30, 2020 | -0.4781 |
| June 30, 2020 | -0.5094 |
| March 31, 2020 | -0.5547 |
| December 31, 2019 | -0.3347 |
| September 30, 2019 | -0.4306 |
| June 30, 2019 | -0.4174 |
| March 31, 2019 | -0.5399 |
| December 31, 2018 | -0.5552 |
| September 30, 2018 | -0.5139 |
| June 30, 2018 | -0.6728 |
| March 31, 2018 | -0.6335 |
| Date | Value |
|---|---|
| December 31, 2017 | -0.4958 |
| September 30, 2017 | -0.2068 |
| June 30, 2017 | -0.26 |
| March 31, 2017 | -0.1536 |
| December 31, 2016 | -0.2412 |
| September 30, 2016 | -0.2228 |
| June 30, 2016 | -0.2267 |
| March 31, 2016 | -0.174 |
| December 31, 2015 | -0.1685 |
| September 30, 2015 | -0.2567 |
| June 30, 2015 | -0.2447 |
| March 31, 2015 | -0.275 |
| December 31, 2014 | -0.3016 |
| September 30, 2014 | -0.2766 |
| June 30, 2014 | -0.2793 |
| March 31, 2014 | -0.2177 |
| December 31, 2013 | -0.1832 |
| September 30, 2013 | -0.1555 |
| June 30, 2013 | -0.1625 |
| March 31, 2013 | -0.1481 |
| December 31, 2012 | -0.1529 |
| September 30, 2012 | -0.9255 |
| June 30, 2012 | -1.044 |
| March 31, 2012 | -1.621 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.5547
Minimum
Mar 2020
-0.2223
Maximum
Dec 2022
-0.3899
Average
-0.3921
Median
Jun 2021
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 0.6381M |
| Total Liabilities (Quarterly) | 24.75M |
| Shareholders Equity (Quarterly) | -24.11M |
| Current Ratio | 0.0008 |
| Net Debt Paydown Yield | 1.21% |